PREEMIE Reauthorization Act of 2018

For activity pertaining to abortion-related components of reconciliation legislation, see BUD (Budget/Appropriations) page. For activity pertaining to other health-care reform ("Obamacare replacement") legislation, see HCR (Health Issues) page. Contacts in support of the Dismemberment Abortion Ban Act (H.R. 1192, Smith), to prohibit a physician from knowingly performing a dismemberment abortion. Contacts in support of the Prenatal Nondiscrimination Act or PRENDA (H.R. 4660, S. 2326), to prohibit discrimination against the unborn on the basis of sex or race. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 4712, S. 220), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital, including a letter to the House dated January 16, 2018, and a letter to the House on Rule resolution H. Res. 694 dated January 17, 2018. (The House passed the bill on January 17, 2018.) Contacts in support of the No Taxpayer Funding for Abortion Act (H.R. 7, S. 184), including letter to House dated January 19, 2017, to codify government-wide policy against funding abortion (passed House January 24, 2017). Contacts in support of Child Interstate Abortion Notification Act (CIANA)(H.R.692, S. 224), to require an abortionist to notify a parent before performing an abortion on a minor from a different state, with certain exceptions. Contacts in support of the Conscience Protection Act (H.R. 644, S. 301), to enhance federal remedies for health-care providers who face government-based discrimination for non-participation in abortion. Contacts in support of Women's Public Health and Safety Act (H.R. 656), to allow a state to exclude certain abortion providers from participation in the state's Medicaid program. Consultations regarding various bills intended to tighten federal limitations on trafficking in tissue from induced abortions (including H.R. 524, H.R. 1203, H.R. 1895, and other draft bills not introduced); no specific legislation endorsed during this quarter. Contacts in support of agency action limiting the use of tissue from aborted babies to the extent permitted by law. Contacts in support of The Protecting the Dignity of Unborn Children Act (H.R. 718), to make it a federal crime to dispose of non-cremated "fetal remains" (from abortions) in a landfill or navigable waterway. Contacts in response to inquiries regarding the Heartbeat Bill (H.R.490) to prohibit abortions if a fetal heartbeat is detectable; no position taken this quarter. Contacts in opposition to "Women's Health Protection Act" (H.R. 1322, S. 510), a proposed federal statute to invalidate virtually all state and federal regulations pertaining to abortion. Contacts in opposition to "EACH Woman Act" (H.R. 771), a bill to mandate coverage of abortion without limitation in Medicaid, Medicare, CHIP, and other federally funded health insurance program, to nullify the laws in effect in about half of the states that restrict coverage of abortion in health plans sold on the Obamacare exchanges, and to nullify all other state laws or policies that "inhibit insurance coverage of abortion by private health plans." Contacts in support of the Patients First Act (H.R. 2918) to require the federal National Institutes of Health to intensify research on types of stem-cell research that do not involve harming human embryos. Responses to inquiries regarding "Life at Conception Act" (H.R. 681, S. 231); nonsupport due to lack of clarity and erroneous legal premises. Contracts regarding abortion-pill reversal and informed consent requirements. Legislation not introduced. Contacts regarding the Maternal Health Accountability Act (S. 1112 and H.R. 1318), related to reporting factors, contract grantee criteria, and potential issues surrounding recommending expansion of abortion access. No position taken this quarter. Contacts in support of a letter requesting that HHS issue new Title X regulations to bar grantees from co-locating with abortion clinics or referring clients for abortions. Contacts regarding the Protecting Health and Wellness of Babies and Pregnant Women in Custody Act (H.R. 6085) as related to potential issues regarding abortion. No position taken this quarter.   Contacts regarding the Quality Care for Moms and Babies Act (S.2637/H.R.5457) as related to potential issues regarding abortion. No position taken this quarter. Supported veto and sustaining of veto of any bill that weakens any existing pro-life policy.  

Client expense: $80,000 · Firm income: Not reported

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

S. 1112 Maternal Health Accountability Act S. 2070 Kevin and Avontes Law S. 2680 Opioid Crisis Response Act S. 3029/H.R. 6085 PREEMIE Reauthorization Act S. 3660 Health Equity & Accountability Act H.R. 6 Support for Patients and Communities Act H.R. 1318 Preventing Maternal Deaths Act H.R. 5102 Substance Use Disorder Workforce Loan Repayment Act FY2019 Defense Appropriations FY2019 Veterans Appropriations

Client expense: $120,000 · Firm income: Not reported

(HR. 6085, S. 3029) PREEMIE Re-authorization Act.

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Health Insurance Coverage (general); Health Disparities (general); Breastfeeding (general); Assisted Reproductive Technology (general); Smoking Cessation (general); Substance Use Disorder (general); Gynecologic Cancer (general); Gynecologic Devices (general); Reproductive Health (general); Intimate Partner Violence (general); Gun Violence (general); Immunization (general); Breast Cancer (general); E-Cigarettes (general); Medical Liability Reform (general); Health IT (general); Patient-Physician Relationship (general); Conscience Refusals (general); Child Welfare (general); Prematurity (general); Maternal Mortality and Morbidity (general); Graduate Medical Education (general); Contraception (general); National Health Service Corps (general); Abortion (general); Hyde Amendment (General); Indian Health (general); Teaching Health Centers (general); Teen Pregnancy Prevention Program (general); Personal Responsibility Education Program (general); Research in Pregnant and Breastfeeding Women (general); Health Care Reform (general); Title X (general); Womens Preventive Services (general); H.R. 5457/S. 2637, Quality Care for Moms and Babies Act; H.R. 1318/S 1112, Preventing Maternal Deaths Act/Maternal Health Accountability Act; H.R. 5977/S. 3776, MOMMAs Act; H.R.5761, Ending Maternal Mortality Act of 2018; S. 3392, MOMs Act; S. 3363, Maternal CARE Act; S.3494, MOMMIES Act; S. 3568, Rural MOMS Act; H.R. 1876/S. 781, Good Samaritan Health Professionals Act; S.2852/H.R. 6378 Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018; S. 783, Improving Access to Maternity Care Act; H.R. 3602/S. 1653, Real Education for Healthy Youth Act; H.R. 6085/S. 3029, the PREEMIE Reauthorization Act; H.R. 4993/S.3253, Vaccine Access Improvement Act of 2018; P.L. 115-271, SUPPORT for Patients and Communities Act; H.R. 6805, Pregnant Women in Custody Act; S. 756, First Step Act; S. 2960 Access to Infertility Treatment and Care Act; H.J.Res. 140/S.J.Res. 63, Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the final rule of the Department of the Treasury, Department of Labor, and the Department of Health and Human Services relating to Short-Term, Limited Duration Insurance; Implementation of P.L. 114-91, Protecting Our Infants Act; Implementation of P.L. 114-198, Comprehensive Addiction and Recovery Act; Implementation of P.L. 114-255, 21st Century Cures Act; H.R. 6545, Violence Against Women Reauthorization Act.

Congressional staff meeting concerning neonatal abstinence syndrome Supporting S. 3029/H.R. 6085, the PREEMIE Reauthorization Act of 2018 Letter to U.S. Health and Human Services Secretary Alex Azar expressing concern over reports that the United States delegation to the 2018 World Health Assembly sought to weaken a resolution designed to support breastfeeding. Letter urging Majority Leader McConnell and Democratic Leader Schumer to include the provision Allowing for More Flexibility with Respect to Medication-Assisted Treatment for Opioid Use Disorders into HR 6, the final Senate opioid package. A letter to House and Senate Leadership in urging them to include Section 3003 Allowing for More Flexibility with Respect to Medication-Assisted Treatment for Opioid Use Disorders, of the House-passed SUPPORT for Families and Communities Act (H.R. 6) within the comprehensive opioid legislation. A letter to Secretary Azar voicing opposition to the Administrations proposed rule changes to Title X Family Planning Programs. A letter supporting HR 1318, the Preventing Maternal Deaths Act.

Client expense: Not reported · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE

Maternal and child health aspects of the All of Us Research Program, National Children's Study (ECHO), Zika preparedness, tobacco control, opioids legislation and neonatal abstinence syndrome (NAS), antibiotic resistance, environmental health, vaccination, newborn screening, Healthy Start, maternal mental health, HR 1318 - Preventing Maternal Deaths Act of 2017 and other maternal mortality prevention bills, S 1112- Maternal Health Accountability Act of 2017, and HR 6085/S 3029- the PREEMIE Reauthorization Act.

Client expense: $20,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Postal Regulatory Commission, SENATE, Treasury, Dept of, U.S. Postal Service (USPS)

For activity pertaining to abortion-related components of reconciliation legislation, see BUD (Budget/Appropriations) page. For activity pertaining to other health-care reform ("Obamacare replacement") legislation, see HCR (Health Issues) page. Contacts in support of the Dismemberment Abortion Ban Act (H.R. 1192, Smith), to prohibit a physician from knowingly performing a dismemberment abortion. Contacts in support of the Prenatal Nondiscrimination Act or PRENDA (H.R. 4660, S. 2326), to prohibit discrimination against the unborn on the basis of sex or race. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 4712, S. 220), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital, including a letter to the House dated January 16, 2018, and a letter to the House on Rule resolution H. Res. 694 dated January 17, 2018. (The House passed the bill on January 17, 2018.) Contacts in support of the No Taxpayer Funding for Abortion Act (H.R. 7, S. 184), including letter to House dated January 19, 2017, to codify government-wide policy against funding abortion (passed House January 24, 2017). Contacts in support of Child Interstate Abortion Notification Act (CIANA)(H.R.692, S. 224), to require an abortionist to notify a parent before performing an abortion on a minor from a different state, with certain exceptions. Contacts in support of the Conscience Protection Act (H.R. 644, S. 301), to enhance federal remedies for health-care providers who face government-based discrimination for non-participation in abortion. Contacts in support of Women's Public Health and Safety Act (H.R. 656), to allow a state to exclude certain abortion providers from participation in the state's Medicaid program. Consultations regarding various bills intended to tighten federal limitations on trafficking in tissue from induced abortions (including H.R. 524, H.R. 1203, H.R. 1895, and other draft bills not introduced); no specific legislation endorsed during this quarter. Contacts in support of agency action limiting the use of tissue from aborted babies to the extent permitted by law. Contacts in support of The Protecting the Dignity of Unborn Children Act (H.R. 718), to make it a federal crime to dispose of non-cremated "fetal remains" (from abortions) in a landfill or navigable waterway. Contacts in response to inquiries regarding the Heartbeat Bill (H.R.490) to prohibit abortions if a fetal heartbeat is detectable; no position taken this quarter. Contacts in opposition to "Women's Health Protection Act" (H.R. 1322, S. 510), a proposed federal statute to invalidate virtually all state and federal regulations pertaining to abortion. Contacts in opposition to "EACH Woman Act" (H.R. 771), a bill to mandate coverage of abortion without limitation in Medicaid, Medicare, CHIP, and other federally funded health insurance program, to nullify the laws in effect in about half of the states that restrict coverage of abortion in health plans sold on the Obamacare exchanges, and to nullify all other state laws or policies that "inhibit insurance coverage of abortion by private health plans." Contacts in support of the Patients First Act (H.R. 2918) to require the federal National Institutes of Health to intensify research on types of stem-cell research that do not involve harming human embryos. Responses to inquiries regarding "Life at Conception Act" (H.R. 681, S. 231); nonsupport due to lack of clarity and erroneous legal premises. Contracts regarding abortion-pill reversal and informed consent requirements. Legislation not introduced. Contacts regarding the Maternal Health Accountability Act (S. 1112 and H.R. 1318), related to reporting factors, contract grantee criteria, and potential issues surrounding recommending expansion of abortion access. No position taken this quarter. Contacts in support of a letter requesting that HHS issue new Title X regulations to bar grantees from co-locating with abortion clinics or referring clients for abortions. Contacts regarding the Protecting Health and Wellness of Babies and Pregnant Women in Custody Act (H.R. 6085) as related to potential issues regarding abortion. No position taken this quarter.   Contacts regarding the Quality Care for Moms and Babies Act (S.2637/H.R.5457) as related to potential issues regarding abortion. No position taken this quarter.  

Preventing Maternal Deaths Act (HR 1318), Maternal Health Accountability Act (S. 1112), pre-term birth, maternal mental health, Quality Care for Moms and Babies Act (S. 2367/HR 5457), Improving Access to Maternity Care Act (S. 783, HR 315); PREEMIE Reauthorization (S. 3029/HR 6085); MOMMA's Act (HR 5977); Ending Maternal Mortality Act (HR 5761); pregnancy research.

Client expense: $20,000 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE

Health Insurance Coverage (general); Health Disparities (general); Breastfeeding (general); Assisted Reproductive Technology (general); Smoking Cessation (general); Substance Use Disorder (general); Gynecologic Cancer (general); Gynecologic Devices (general); Reproductive Health (general); Intimate Partner Violence (general); Gun Violence (general); Immunization (general); Breast Cancer (general); E-Cigarettes (general); Medical Liability Reform (general); Health IT (general); Patient-Physician Relationship (general); Conscience Refusals (general); Child Welfare (general); Prematurity (general); Health Disparities (general); Maternal Mortality and Morbidity (general); Graduate Medical Education (general); Lab Developed Tests (general); Contraception (general); Preeclampsia (general); Over the Counter Drugs (general); National Health Service Corps (general); Community Health Centers (general); Abortion (general); Hyde Amendment (General); Indian Health (general); Teaching Health Centers (general); Teen Pregnancy Prevention Program (general); Research in Pregnant and Breastfeeding Women (general); Healthy Start (general); Health Care Reform (general); Title X (general); Personal Responsibility Education Program (general); Womens Preventive Services (general); H.R. 5457/S. 2637, Quality Care for Moms and Babies Act; H.R. 1318/S 1112, Preventing Maternal Deaths Act/Maternal Health Accountability Act; H.R. 5977, MOMMAs Act; H.R.5761, Ending Maternal Mortality Act of 2018; S. 3392, MOMs Act; S. 3363, Maternal CARE Act; S.3494, MOMMIES Act; H.R. 1876/S. 781, Good Samaritan Health Professionals Act; S.2852/H.R. 6378 Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018; S. 783, Improving Access to Maternity Care Act; S.Res. 605, A resolution designating the first week in August as World Breastfeeding Week, and designating August as National Breastfeeding Month; H.R. 3602/S. 1653, Real Education for Healthy Youth Act; H.R. 421/S. 93, Allowing Greater Access to Safe and Effective Contraception Act; H.R. 6085/S. 3029, the PREEMIE Reauthorization Act; H.R. 3692, Addiction Treatment Access Improvement Act; S. 2680, Opioid Crisis Response Act; H.R. 5818/S. 2843, the Opioid Workforce Act of 2018; H.R. 2501/S. 1148, CRIB Act; H.R. 4993/ S.3253 - Vaccine Access Improvement Act of 2018; H.R. 6, SUPPORT for Patients and Communities Act; H.R. 6805, Pregnant Women in Custody Act; S. 2960 Access to Infertility Treatment and Care Act; H.J.Res. 140/S.J.Res. 63, Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the final rule of the Department of the Treasury, Department of Labor, and the Department of Health and Human Services relating to Short-Term, Limited Duration Insurance; Implementation of P.L. 114-91, Protecting Our Infants Act; Implementation of P.L. 114-198, Comprehensive Addiction and Recovery Act; Implementation of P.L. 114-255, 21st Century Cures Act; H.R. 6545/S.___, Violence Against Women Reauthorization Act.

(HR. 6085, S. 3029) PREEMIE Re-authorization Act.

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 1112 Maternal Health Accountability Act S. 1570/HR 3273 LGBT Inclusion Act S. 2070 Kevin and Avontes Law S. 2584/HR 5374 Student non-Discrimination ActS. 2680 Opioid Crisis Response Act S. 2680 Opioid Crisis Response Act S. 2754 Handle with Care Act S. 3029/H.R. 6085 PREEMIE Reauthorization Act H.R. 1 Tax Cuts and Jobs Act H.R. 6 Support for Patients and Communities Act H.R. 4684 Ensuring Access to Quality Sober Living Act H.R. 4733 Opioids and STOP Pain Initiative Act H.R. 5102 Substance Use Disorder Workforce Loan Repayment Act H.R. 5475 Health Equity and Accountability Act FY2019 Defense Appropriations FY2019 Veterans Appropriations Childrens Health Insurance Program (CHIP) reauthorization Bipartisan Health Care Stabilization Act VA Mission Act

Client expense: $160,000 · Firm income: Not reported

To Congress: - Urging Congress to block "short-term, limited-duration" insurance (STLD) insurance plans as proposed by the administration - Expressing support for the Health Equity and Accountability Act - Expressing support for the ABLE Age Adjustment Act (S. 817/HR 1874) - Expressing support for S. 3029/H.R. 6085, the PREEMIE Reauthorization Act of 2018 To the administration: - Comments to HHS, Labor, Treasury about proposed rule on STLD insuarnce plans (CMS-9924-P) - Urging FDA and HHS to finalize rule to ban electrical stimulation devices for treatment of autism - Urging HHS to evaluate work requirements before approving more Medicaid Sec. 1115 waivers - Urging CMS to rescind invitation to states to institute Medicaid work requirements - Comments on proposed rule re: Medicaid assessments of access in fee-for-service plans in states with high concentrations of managed care (CMS-2018-0031-0001) - Comments on proposed waiver for Florida to eliminate retroactive Medicaid eligibility - Expressing concern about Medicaid waiver proposals, impact on children's general and oral health - Urging HHS to implement RAISE Family Caregivers Act - General Family Voices statement urging the administration to promptly reunite immigrant children and families, to ensure proper health care for children with special health care needs, and to provide counseling and support to children and families after reunification

Client expense: Not reported · Firm income: $10,000

Supporting H.R.1318 - Preventing Maternal Deaths Act of 2017 Supporting S.1112 - Maternal Health Accountability Act of 2017 Supporting H.R.947 - Family and Medical Insurance Leave (FAMILY) Act Supporting S.337 - Family and Medical Insurance Leave (FAMILY) Act Suppporting H.R.3692 - Addiction Treatment Access Improvement Act of 2017 Supporting S.2317 - Addiction Treatment Access Improvement Act of 2018 Supporting S. 3029/H.R. 6085, the PREEMIE Reauthorization Act of 2018 Supporting HR 6 SUPPORT for Patients and Communities Act Concerning S.2680 Opioid Crisis Response Act of 2018. Supporting S.2658 Protecting Newborns from Opioids Act. The National Sample Survey of Registered Nurses. The nurse faculty shortage The focus of Title VIII grants on addressing the opioid epidemic.

Client expense: $6,590 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Homeland Security, Dept of (DHS), President of the U.S., SENATE

Preventing Maternal Deaths Act (HR 1318), Maternal Health Accountability Act (S. 1112), pre-term birth, maternal mental health, Quality Care for Moms and Babies Act (S. 2367/HR 5457), Improving Access to Maternity Care Act (S. 783, HR 315); PREEMIE Reauthorization (S. 3029/HR 6085); MOMMA's Act (HR 5977); Ending Maternal Mortality Act (HR 5761); pregnancy research.

Client expense: $20,000 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE

Health Insurance Coverage (general); Genetic Screening and Testing (general); Health Disparities (general); Breastfeeding (general); Pregnancy Intention (general); Assisted Reproductive Technology (general); Smoking Cessation (general); Substance Use Disorder (general); Gynecologic Cancer (general); Gynecologic Devices (general); Reproductive Health (general); Intimate Partner Violence (general); Gun Violence (general); Immunization (general); Breast Cancer (general); E-Cigarettes (general); Medical Liability Reform (general); Health IT (general); Patient-Physician Relationship (general); Conscience Refusals (general); Child Welfare (general); Prematurity (general); Health Disparities (general); Maternal Mortality and Morbidity (general); Graduate Medical Education (general); Lab Developed Tests (general); Stem Cell Research (general); Contraception (general); Preeclampsia (general); Drug Pricing (general); Over the Counter Drugs (general); National Health Service Corps (general); Community Health Centers (general); Abortion (general); Hyde Amendment (General); Indian Health (general);; Teaching Health Centers (general); ; Teen Pregnancy Prevention Program (general); Research in Pregnant and Breastfeeding Women (general); Healthy Start (general); Zika Virus (general); Health Care Reform (general); Title X (general); Personal Responsibility Education Program (general); Womens Preventive Services (general); H.R. 5457/S. 2637, Quality Care for Moms and Babies Act; H.R. 1318/S 1112, Preventing Maternal Deaths Act/Maternal Health Accountability Act; H.R. ___, MOMMAs Act; H.R.5761 - Ending Maternal Mortality Act of 2018; H.R. 1876/S. 781, Good Samaritan Health Professionals Act; H.R. 1215/S.___ Protecting Access to Care Act; H.R. 1565, Saving Lives, Saving Costs Act; S.2852/H.R. 6378 Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018; H.R. 3120, To amend title XVIII of the Social Security Act to reduce the volume of future electronic health record-related significant hardship requests; S. 783, Improving Access to Maternity Care Act; ; H.R. 3602/S. 1653, Real Education for Healthy Youth Act; H.R. 421/S. 93, Allowing Greater Access to Safe and Effective Contraception Act; ; H.R. 6085/S. 3029, the PREEMIE Reauthorization Act; H.R. 3692, Addiction Treatment Access Improvement Act; H.R. 5272, Reinforcing Evidence-Based Standards Under Law in Treating Substance Abuse Act; S. 2680, Opioid Crisis Response Act; H.R. 5562, Protecting NAS Babies Act; H.R. 2501/S. 1148, CRIB Act; H.R.___ Medicaid Partnership Act; H.R.___ To amend title XIX of the Social Security Act to provide for a demonstration project to increase substance use provider capacity under the Medicaid program; H.R. 3192, CHIP Mental Health Parity Act; H.R. ___, Incentivizing Non-Opioid Drugs; H.R. 6, SUPPORT for Patients and Communities Act; S. 3120, HEAL Act; S. 1113, Personal Care Products Safety Act; S. ___, Bipartisan Heath Care Stabilization Act; H.Res. 818/S.Res.459, Recognizing Black Maternal Health Week to bring national attention to the maternal health care crisis in the Black community and the importance of reducing the rate of maternal mortality and morbidity among Black Women; H. ___, Diagnostic Accuracy and Innovation Act (DAIA); S. 2960 Access to Infertility Treatment and Care Act; H.R.___/S.___ Violence Against Women Act; Implementation of P.L. 114-91, Protecting Our Infants Act; Implementation of P.L. 114-198, Comprehensive Addiction and Recovery Act; Implementation of P.L. 114-255, 21st Century Cures Act.

(HR. 6085, S. 3029) PREEMIE Re-authorization Act.

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 1112 Maternal Health Accountability Act S. 2070 Kevin and Avontes Law S. 2193 Caring for Our Veterans Act S. 2680 Opioid Crisis Response Act S. 2754 Handle with Care Act S. 3029/H.R. 6085 PREEMIE Reauthorization Act H.R. 1 Tax Cuts and Jobs Act H.R. 4684 Ensuring Access to Quality Sober Living Act H.R. 4733 Opioids and STOP Pain Initiative Act H.R. 5102 Substance Use Disorder Workforce Loan Repayment Act H.R. 5475 Health Equity and Accountability Act FY2019 Defense Appropriations FY2019 Veterans Appropriations Childrens Health Insurance Program (CHIP) reauthorization Bipartisan Health Care Stabilization Act

Client expense: $260,000 · Firm income: Not reported

S 3209/ HR 6085 PREEMIE Act; Reauthorization of the New Born Screening Saves Lives Act; FY19 Labor, Health and Human Services, and Education Appropriations bills regarding provisions related to preventing premature births

Client expense: Not reported · Firm income: Not reported